News Ticker

[ September 29, 2023 ] Health research funding to Oregon slowed in 2022 News
[ September 29, 2023 ] Legacy doctors and nurse practitioners file for union recognition News
[ September 29, 2023 ] Exclusive: Former Genentech duo reunites to push Sonoma into the clinic; Ex-Magenta commercial chief heads to Editas News
[ September 29, 2023 ] Sonoma Biotherapeutics Appoints Joseph R. Arron, M.D., Ph.D., as Chief Scientific Officer and Mark D. Eisner, M.D., MPH, as Chief Medical Officer News
[ September 29, 2023 ] Associate Director, Bioassays – Absci – Vancouver, WA Jobs

NanoString Technologies Releases Fourth Quarter and Full Year 2022 Operating Results and Provides 2023 Financial Outlook

February 28, 2023 WOBN News Comments Off

SEATTLE–(BUSINESS WIRE)– #earnings–NanoString reports Q4 and FY22 operating results.
Click here to view original post

Copyright © 2023 Biotech Networks, LLC